Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

KALEIDO BIOSCIENCES, INC.

(KLDO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023
Capitalization1 15132789,489,4-
Enterprise Value (EV)1 97,730283,626,0-38,3
P/E ratio -1,49x-3,73x-0,93x-1,05x-1,13x
Yield -----
Capitalization / Revenue -336x55,7x168x4,20x
EV / Revenue -310x52,1x48,8x-1,80x
EV / EBITDA -1,14x-3,92x-0,91x-0,22x0,33x
Price to Book 3,09x16,0x36,9x2,01x1,21x
Nbr of stocks (in thousands) 30 04135 98242 59442 594-
Reference price (USD) 5,029,102,102,102,10
Announcement Date 03/02/202003/03/2021---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales1 --0,981,610,5321,3
EBITDA1 -59,9-85,3-77,1-91,7-117-117
Operating profit (EBIT)1 --86,7-78,9-92,8-110-104
Operating Margin ---8 090%-5 776%-20 553%-488%
Pre-Tax Profit (EBT)1 --86,3-81,6-94,4-106-90,3
Net income1 -61,7-86,3-81,6-94,6-106-95,1
Net margin ---8 371%-5 890%-19 886%-447%
EPS2 -12,1-3,36-2,44-2,25-1,99-1,86
Dividend per Share ------
Announcement Date 02/19/201903/02/202003/03/2021---
1 USD in Million
2 USD
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q1 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2
Net sales1 0,300,210,101,120,130,13
EBITDA1 -21,8-22,6-21,8-24,0--
Operating profit (EBIT)1 -22,3-23,2-22,4-24,3-24,3-25,8
Operating Margin -7 525%-10 999%-21 551%-2 173%-19 400%-20 600%
Pre-Tax Profit (EBT)1 -23,0-23,9-23,1-24,4-25,0-26,6
Net income1 -23,0-23,9-23,1-24,4-25,0-26,6
Net margin -7 758%-11 322%-22 197%-2 181%-20 000%-21 240%
EPS2 -0,58-0,56-0,54-0,57-0,46-0,48
Dividend per Share ------
Announcement Date 05/04/202108/11/202111/01/2021---
1 USD in Million
2 USD
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt1 ------
Net Cash position1 -53,125,25,8363,4128
Leverage (Debt / EBITDA) -0,62x0,33x0,06x0,54x1,10x
Free Cash Flow1 --79,4-65,5-81,0-100-
ROE (Net Profit / Equities) ---235%-866%-841%-379%
Shareholders' equity1 --34,710,912,625,1
ROA (Net Profit / Asset) --103%-115%-165%-214%-198%
Assets1 -83,870,857,249,648,1
Book Value Per Share2 -1,620,570,061,041,73
Cash Flow per Share ------
Capex1 3,003,594,021,593,711,71
Capex / Sales --413%99,3%696%8,04%
Announcement Date 02/19/201903/02/202003/03/2021---
1 USD in Million
2 USD
Key data
Capitalization (USD) 89 448 135
Net sales (USD) 975 000
Number of employees 82
Sales / Employee (USD) 11 890
Free-Float 91,0%
Free-Float capitalization (USD) 81 382 434
Avg. Exchange 20 sessions (USD) 325 978
Average Daily Capital Traded 0,36%
EPS & Dividend